Champions Oncology Inc. logo

Champions Oncology Inc.

CSBR | NASDAQ
Chart Builder DCF Calculator
$4.81
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$4.81
$0.00 (0.00%)
After-hours: Oct 30, 2026, 4:00 PM ET
Fiscal Quarter
Period Ending
Q1 2027
Jul 31, 2026
Q4 2026
Apr 30, 2026
Q3 2026
Jan 31, 2026
Q2 2026
Oct 31, 2025
Q1 2026
Jul 31, 2025
Q4 2025
Apr 30, 2025
Q3 2025
Jan 31, 2025
Q2 2025
Oct 31, 2024
Q1 2025
Jul 31, 2024
Q4 2024
Apr 30, 2024
Q3 2024
Jan 31, 2024
Q2 2024
Oct 31, 2023
Q1 2024
Jul 31, 2023
Q4 2023
Apr 30, 2023
Q3 2023
Jan 31, 2023
Q2 2023
Oct 31, 2022
Q1 2023
Jul 31, 2022
Q4 2022
Apr 30, 2022
Q3 2022
Jan 31, 2022
Q2 2022
Oct 31, 2021
Q1 2022
Jul 31, 2021
Net Income
-426K -667K -278K 236K -466K -1.84M 4.5M 728K 1.31M -109K -2.53M -2.07M -2.57M -2.56M -2.44M -16K -319K -344K 787K 277K -172K
Depreciation & Amortization
314K 321K 341K 357K 358K 394K 398K 399K 449K 457K 481K 484K 445K 583K 575K 560K 528K 568K 396K 346K 317K
Stock-Based Compensation
766K 357K 423K 249K 208K 131K 256K 9K 258K 263K 379K 53K 423K 208K 331K 119K 206K 188K 310K 134K 280K
Other Working Capital
418K -2.5M 4.21M -2.24M -1.97M 3.84M 543K 107K -1.93M -2.48M 403K 1.83M -2.05M -942K 2.24M -124K -706K 1.88M 2.85M 520K -775K
Other Non-Cash Items
275K 403K -4.63M 428K 301K 451K 258K 85K 218K -242K 376K 369K 432K 1.05M 228K 403K 269K 426K 16K 313K 245K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 74K
Change in Working Capital
-1.42M -2.41M 2.81M -3.01M 199K 7.73M -4.92M -1.5M -1.93M -3.23M 375K 1.75M -2.73M 24K 2.88M 2.22M -879K -42K 2.75M 158K -528K
Operating Cash Flow
-492K -2M -1.34M -1.74M 600K 6.87M 490K -283K 311K -1.82M -919K 589K -3.99M -692K 1.57M 3.29M -195K 796K 4.26M 1.23M 216K
Capital Expenditures
-55K -239K -37K -242K -46K -253K -42K -94K n/a 111K -126K -153K -668K -760K -754K -604K -754K -506K -405K -566K -907K
Cash Acquisitions
n/a n/a 23K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-55K -238K -14K -242K -46K -253K -42K -94K n/a 111K -92K -153K -668K -760K -754K -604K -754K -506K -405K -566K -907K
Debt Repayment
-19K -19K -39K -39K -38K -38K -38K -37K -37K -146K -34K -74K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -32K -602K -74K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 314K 12K n/a n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
33K -19K -36K 168K -14K -32K n/a 239K -37K -145K -34K 208K -590K -75K n/a 86K n/a 16K 68K 121K 2K
Net Cash Flow
-514K -2.26M -1.39M -1.81M 540K 6.58M 448K -138K 274K -1.85M -1.05M 644K -5.25M -1.53M 819K 2.77M -949K 306K 3.92M 783K -689K
Free Cash Flow
-547K -2.24M -1.38M -1.98M 554K 6.62M 448K -377K 311K -1.71M -1.05M 436K -4.66M -1.45M 819K 2.68M -949K 290K 3.85M 662K -691K
Adj. Free Cash Flow
-1.31M -2.59M -1.8M -2.23M 346K 6.48M 192K -386K 53K -1.97M -1.42M 383K -5.08M -1.66M 488K 2.56M -1.16M 102K 3.54M 528K -971K
Maintenance CapEx
-55K n/a -37K n/a -46K -253K n/a n/a n/a 222K -126K -153K -668K -713.61K -754K -7.42K -158.14K n/a n/a -198.22K -530.85K
Growth CapEx
n/a -239K n/a -242K n/a n/a -42K -94K n/a -111K n/a n/a n/a -46.39K n/a -596.58K -595.86K -506K -405K -367.78K -376.16K
Owner Earnings
-547K -2M -1.38M -1.74M 554K 6.62M 490K -283K 311K -1.59M -1.05M 436K -4.66M -1.41M 819K 3.28M -353.14K 796K 4.26M 1.03M -314.85K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.